| Year |
Citation |
Score |
| 2022 |
Nicolae A, Bouilly J, Lara D, Fataccioli V, Lemonnier F, Drieux F, Parrens M, Robe C, Poullot E, Bisig B, Bossard C, Letourneau A, Missiaglia E, Bonnet C, Szablewski V, et al. Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 35301414 DOI: 10.1038/s41379-022-01022-w |
0.315 |
|
| 2022 |
Ducoin K, Oger R, Bilonda Mutala L, Deleine C, Jouand N, Desfrançois J, Podevin J, Duchalais E, Cruard J, Benlalam H, Labarrière N, Bossard C, Jarry A, Gervois-Segain N. Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer. Oncoimmunology. 11: 2046931. PMID 35295095 DOI: 10.1080/2162402X.2022.2046931 |
0.318 |
|
| 2021 |
Denis Musquer M, Jouand N, Pere M, Lamer JE, Bézieau S, Matysiak T, Faroux R, Caroli Bosc FX, Rousselet MC, Leclair F, Mosnier JF, Toquet C, Gervois N, Bossard C. High-Density of FcγRIIIA (CD16) Tumor-Associated Neutrophils in Metastases Improves the Therapeutic Response of Cetuximab in Metastatic Colorectal Cancer Patients, Independently of the HLA-E/CD94-NKG2A Axis. Frontiers in Oncology. 11: 684478. PMID 34211852 DOI: 10.3389/fonc.2021.684478 |
0.6 |
|
| 2020 |
Hulo P, Touchefeu Y, Cauchin E, Archambeaud I, Chapelle N, Bossard C, Bennouna J. Acute Ulceronecrotic Gastritis With Cytomegalovirus Reactivation: Uncommon Toxicity of Immune Checkpoint Inhibitors in Microsatellite Instability-High Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 19: e183-e188. PMID 32703755 DOI: 10.1016/J.Clcc.2020.04.006 |
0.309 |
|
| 2020 |
Quénéhervé L, Olivier R, Gora MJ, Bossard C, Mosnier JF, Benoit A la Guillaume E, Boccara C, Brochard C, Neunlist M, Coron E. Full-field optical coherence tomography: novel imaging technique for extemporaneous high-resolution analysis of mucosal architecture in human gut biopsies. Gut. PMID 32447309 DOI: 10.1136/Gutjnl-2020-321228 |
0.546 |
|
| 2019 |
Valès S, Bacola G, Biraud M, Touvron M, Bessard A, Geraldo F, Dougherty KA, Lashani S, Bossard C, Flamant M, Duchalais E, Marionneau-Lambot S, Oullier T, Oliver L, Neunlist M, et al. Tumor cells hijack enteric glia to activate colon cancer stem cells and stimulate tumorigenesis. Ebiomedicine. PMID 31662289 DOI: 10.1016/J.Ebiom.2019.09.045 |
0.365 |
|
| 2019 |
Duval L, Habes S, Chatellier T, Guerzider P, Bossard C, Masliah C, Archambeaud I, Touchefeu Y, Matysiak-Budnik T. Nivolumab-induced celiac-like enteropathy in patient with metastatic renal cell carcinoma: Case report and review of the literature. Clinical Case Reports. 7: 1689-1693. PMID 31534728 DOI: 10.1002/Ccr3.2342 |
0.308 |
|
| 2019 |
Drieux F, Ruminy P, Abdel-Sater A, Lemonnier F, Viailly PJ, Fataccioli V, Machand V, Bisig B, Letourneau A, Parrens M, Bossard C, Bruneau J, Dobay P, Veresezan L, Dupuy A, et al. Defining the signatures of peripheral T-cell lymphoma, with a targeted 20-markers gene expression profiling assay (RT-MLPA). Haematologica. PMID 31488561 DOI: 10.3324/Haematol.2019.226647 |
0.345 |
|
| 2019 |
Eugène J, Jouand N, Ducoin K, Dansette D, Oger R, Deleine C, Leveque E, Meurette G, Podevin J, Matysiak T, Bennouna J, Bezieau S, Volteau C, Thomas WEA, Chetritt J, ... ... Bossard C, et al. The inhibitory receptor CD94/NKG2A on CD8 tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 31409873 DOI: 10.1038/S41379-019-0322-9 |
0.638 |
|
| 2019 |
Ott E, Bilonda L, Dansette D, Deleine C, Duchalais E, Podevin J, Volteau C, Bennouna J, Touchefeu Y, Fourquier P, El Alami Thomas W, Chetritt J, Bezieau S, Denis M, Toquet C, ... ... Bossard C, et al. The density of Tbet+ tumor-infiltrating T lymphocytes reflects an effective and druggable preexisting adaptive antitumor immune response in colorectal cancer, irrespective of the microsatellite status. Oncoimmunology. 8: e1562834. PMID 30906656 DOI: 10.1080/2162402X.2018.1562834 |
0.597 |
|
| 2019 |
Bossenmeyer C, Duchalais E, Moreau A, Bossard C. Unexpected DOG1 expression in gastrointestinal neuroectodermal tumor of the rectum: A diagnostic pitfall Human Pathology: Case Reports. 17: 200317. DOI: 10.1016/J.Ehpc.2019.200317 |
0.303 |
|
| 2019 |
Bossard C, Laghmari O, Bris YL, Bonnet A, Moreau A, Thomas WEA, Pavageau A, Guerzider P, Maisonneuve H, Ruminy P, Bene M, Casasnovas O, Canioni D, Thieblemont C, Petrella T, et al. Refinement Of Mum1 Expression Threshold For Double Positive Cd10+ Mum1+ Diffuse Large B Cell Lymphoma Allows A Better Cell Of Origin Classification For Gcb Subtype Hematological Oncology. 37: 197-198. DOI: 10.1002/Hon.11_2630 |
0.322 |
|
| 2018 |
Sarkozy C, Copie-Bergmand C, Damotte D, Ben-Neriah S, Burroni B, Cornillon J, Lemal R, Golfier C, Fabiani B, Chassagne-Clément C, Parrens M, Herbaux C, Xerri L, Bossard C, Laurent C, et al. Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma: A Histopathologic Series From the LYSA. The American Journal of Surgical Pathology. PMID 30540571 DOI: 10.1097/Pas.0000000000001198 |
0.347 |
|
| 2018 |
Bou-Hanna C, Jarry A, Mosnier JF, Bossard C, Laboisse CL. The double stranded RNA analog poly-IC elicits both robust IFN-λ production and oncolytic activity in human gastrointestinal cancer cells. Oncotarget. 9: 34471-34484. PMID 30349642 DOI: 10.18632/Oncotarget.26121 |
0.583 |
|
| 2018 |
Godefroy E, Alameddine J, Montassier E, Mathé J, Desfrançois-Noël J, Marec N, Bossard C, Jarry A, Bridonneau C, Le Roy A, Sarrabayrouse G, Kerdreux E, Bourreille A, Sokol H, Jotereau F, et al. Expression of CCR6 and CXCR6 by Gut-derived CD4/CD8alpha T-regulatory Cells Which are Decreased in Blood Samples From Patients With Inflammatory Bowel Diseases. Gastroenterology. PMID 29981781 DOI: 10.1053/J.Gastro.2018.06.078 |
0.368 |
|
| 2018 |
Duchalais E, Guilluy C, Nedellec S, Touvron M, Bessard A, Touchefeu Y, Bossard C, Boudin H, Louarn G, Neunlist M, Van Landeghem L. Colorectal Cancer Cells Adhere to and Migrate Along the Neurons of the Enteric Nervous System. Cellular and Molecular Gastroenterology and Hepatology. 5: 31-49. PMID 29188232 DOI: 10.1016/J.Jcmgh.2017.10.002 |
0.348 |
|
| 2018 |
Hurabielle C, Sbidian E, Beltraminelli H, Bouchindhomme B, Chassagne-Clément C, Balme B, Bossard C, Delfau-Larue M, Wolkenstein P, Chosidow O, Cordonnier C, Toma A, Pautas C, Ortonne N. Eruption of lymphocyte recovery with atypical lymphocytes mimicking a primary cutaneous T-cell lymphoma: a series of 12 patients. Human Pathology. 71: 100-108. PMID 29107664 DOI: 10.1016/J.Humpath.2017.10.018 |
0.37 |
|
| 2018 |
Broutin S, Lemonnier F, Dupuy A, Delahousse J, Fataccioli V, Ribrag V, Safar V, Pelletier L, Robe C, Tilly H, Cottereau AS, Bossard C, Leval Ld, Delfau M, Haioun C, et al. Serum 2-Hydroxyglutarate in Angioimmunoblastic T Cell Lymphomas: A New Marker for IDH2 Mutation Detection and Monitoring Blood. 132: 2898-2898. DOI: 10.1182/Blood-2018-99-115893 |
0.31 |
|
| 2018 |
Barret JM, Meseure D, Bataillon G, Andersson N, Auguste A, Dubreuil O, Färkkilä A, Perrial E, Bossard C, Loison E, Jarry A, Nicolas A, Lemée F, Gaillard S, Lahmar M, et al. Abstract 774: Anti-Müllerian hormone type II receptor (AMHRII) found expressed in human non-gynecological solid tumors, suggesting potential broader applications for anti-AMHRII-based therapy Cancer Research. 78: 774-774. DOI: 10.1158/1538-7445.Am2018-774 |
0.36 |
|
| 2018 |
Bilonda L, Dansette D, Deleine C, Oger R, Jouand N, Podevin J, Fourquier P, Thibaudeau E, Chetritt J, Mosnier J, Bossard C, Gervois N, Jarry A. Abstract 4061: The inflammasome of tumor cells modulates the biology of tumor-infiltrating T lymphocytes in colorectal cancer Tumor Biology. DOI: 10.1158/1538-7445.Am2018-4061 |
0.605 |
|
| 2017 |
Laurent C, Baron M, Amara N, Haioun C, Dandoit M, Maynadié M, Parrens M, Vergier B, Copie-Bergman C, Fabiani B, Traverse-Glehen A, Brousse N, Copin MC, Tas P, Petrella T, ... ... Bossard C, et al. Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016712083. PMID 28459613 DOI: 10.1200/Jco.2016.71.2083 |
0.313 |
|
| 2017 |
Jarry A, Malard F, Bou-Hanna C, Meurette G, Mohty M, Mosnier JF, Laboisse CL, Bossard C. Interferon-Alpha Promotes Th1 Response and Epithelial Apoptosis via Inflammasome Activation in Human Intestinal Mucosa. Cellular and Molecular Gastroenterology and Hepatology. 3: 72-81. PMID 28174758 DOI: 10.1016/J.Jcmgh.2016.09.007 |
0.555 |
|
| 2017 |
Bossard C, Dansette D, Ouairy A, Jouand N, Oger R, Bou-Hanna C, Laboisse C, Mosnier J, Gervois N, Jarry A. Role of the inflammasome of tumor cells in modulating the biology of Tumor Infiltrating T lymphocytes (TILs) in colorectal cancer. Journal of Clinical Oncology. 35: 640-640. DOI: 10.1200/Jco.2017.35.4_Suppl.640 |
0.64 |
|
| 2017 |
Bossard C, Ott E, Dansette D, Ouary A, Jarry A, Bezieau S, Toquet C, Mosnier J. Potential therapeutic target for PD1/PDL1 blockade in microsatellite medullary carcinomas based on PDL1 expression by tumor cells and infiltration by numerous PD1+ T lymphocytes. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E14599 |
0.569 |
|
| 2017 |
Bossard C, Eugene J, Jouand N, Dansette D, Leveque E, Podevin J, Matysiak T, Bezieau S, Chetritt J, Kerdraon O, Fourquier P, Thibaudeau E, Mosnier J, Jarry A, Gervois N. Intraepithelial CD94+ tumor-infiltrating lymphocytes in a context of HLA-E overexpression as a new immune checkpoint to predict prognosis in colorectal carcinomas. Journal of Clinical Oncology. 35: e14592-e14592. DOI: 10.1200/Jco.2017.35.15_Suppl.E14592 |
0.616 |
|
| 2017 |
Lemonnier F, Safar V, Cottereau A, Fataccioli V, Chaillol I, Pelletier R, Letourneau A, Dupuy A, Bossard C, Martin A, Robe C, Pelletier L, Pujals A, Bachy E, Delmer A, et al. Integrative Analysis Of Features Associated With Tet2, Idh2, Dnmt3A, And Rhoa Mutations In Angioimmunoblastic T Cell Lymphoma: A Lysa Study Hematological Oncology. 35: 165-167. DOI: 10.1002/Hon.2438_23 |
0.319 |
|
| 2017 |
Ruminy P, Drieux F, Sater AA, Fataccioli V, Marchand V, Parrens M, Bossard C, Dobay P, Viailly P, Veresezan L, Dupuy A, Pujals A, Picquenot J, Tilly H, Leval LD, et al. GENE EXPRESSION PROFILING USING a RTMLPA ASSAY ALLOWS FOR AN ACCURATE CLASSIFICATION OF PERIPHERAL T-CELL LYMPHOMA AND HIGHLIGHTS NOVEL SUBGROUPS WITHIN PTCLS-NOS Hematological Oncology. 35: 74-75. DOI: 10.1002/Hon.2437_62 |
0.318 |
|
| 2016 |
Brocard A, Knol AC, Bossard C, Denis MG, Quéreux G, Saint-Jean M, Peuvrel L, Khammari A, Blancho G, Dantal J, Dréno B. Clinical, Genetic and Innate Immunity Characteristics of Melanoma in Organ Transplant Recipients. Acta Dermato-Venereologica. PMID 27868139 DOI: 10.2340/00015555-2568 |
0.32 |
|
| 2016 |
Touchefeu Y, Provost-Dewitte M, Lecomte T, Morel A, Valo I, Mosnier JF, Bossard C, Eugène J, Duchalais E, Chetritt J, Guyetant S, Bézieau S, Senellart H, Caulet M, Cauchin E, et al. Clinical, histological, and molecular risk factors for cancer recurrence in patients with stage II colon cancer. European Journal of Gastroenterology & Hepatology. PMID 27606947 DOI: 10.1097/Meg.0000000000000725 |
0.586 |
|
| 2016 |
Roberti A, Dobay MP, Bisig B, Vallois D, Boéchat C, Lanitis E, Bouchindhomme B, Parrens MC, Bossard C, Quintanilla-Martinez L, Missiaglia E, Gaulard P, Leval Ld. Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations. Nature Communications. 7: 12602. PMID 27600764 DOI: 10.1038/Ncomms12602 |
0.356 |
|
| 2016 |
Bourcier J, Gastinne T, Leux C, Moreau A, Bossard C, Mahé B, Blin N, Dubruille V, Touzeau C, Voldoire M, Guillaume T, Peterlin P, Gallas P, Garnier A, Maisonneuve H, et al. Rituximab maintenance after autologous stem cell transplantation prolongs response duration in non-naive rituximab follicular lymphoma patients: a single institution experience. Annals of Hematology. PMID 27297970 DOI: 10.1007/S00277-016-2705-Z |
0.302 |
|
| 2016 |
Drieux F, Ruminy P, Fataccioli V, Marchand V, Parrens M, Bossard C, Viailly PJ, Dobay MP, Veresezan EL, Pujals A, Dupuy A, Picquenot J, Tilly H, Leval Ld, Jardin F, et al. Gene Expression Profiling Using a Reverse Transcriptase-Multiplex Ligation Dependant Probe Amplification Assay Allows for an Accurate Classification of Peripheral T-Cell Lymphoma and Highlights Novel Subgroups within the PTCL-NOS Category Blood. 128: 2932-2932. DOI: 10.1182/Blood.V128.22.2932.2932 |
0.39 |
|
| 2015 |
Lamarque M, Bossard C, Contejean A, Brice P, Parrens M, Le Gouill S, Brière J, Bouabdallah R, Canioni D, Tilly H, Bouchindhomme B, Bachy E, Delarue R, Haioun C, Gaulard P. Brentuximab vedotin in refractory or relapsed Peripheral T-cell Lymphomas: The French named patient program experience in 56 patients. Haematologica. PMID 26703966 DOI: 10.3324/Haematol.2015.135400 |
0.347 |
|
| 2015 |
Jarry A, Bossard C, Droy-Dupré L, Volteau C, Bourreille A, Meurette G, Mosnier JF, Laboisse CL. Heterogeneity of subordination of the IL-18/IFN-γ axis to caspase-1 among patients with Crohn's disease. Laboratory Investigation; a Journal of Technical Methods and Pathology. 95: 1207-17. PMID 26168332 DOI: 10.1038/Labinvest.2015.89 |
0.593 |
|
| 2015 |
Lamarthée B, Malard F, Gamonet C, Bossard C, Couturier M, Renauld JC, Mohty M, Saas P, Gaugler B. Donor interleukin-22 and host type I interferon signaling pathway participate in intestinal graft-versus-host disease via STAT1 activation and CXCL10. Mucosal Immunology. PMID 26153763 DOI: 10.1038/Mi.2015.61 |
0.318 |
|
| 2015 |
de Leval L, Parrens M, Le Bras F, Jais JP, Fataccioli V, Martin A, Lamant L, Delarue R, Berger F, Arbion F, Bossard C, Copin MC, Canioni D, Charlotte F, Damaj G, et al. ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA IS THE MOST COMMON T-CELL LYMPHOMA IN TWO DISTINCT FRENCH INFORMATION DATA SETS. Haematologica. PMID 26045291 DOI: 10.3324/Haematol.2015.126300 |
0.305 |
|
| 2015 |
Brégeon J, Neunlist M, Bossard C, Biraud M, Coron E, Bourreille A, Meurette G. Improvement of Refractory Ulcerative Proctitis With Sacral Nerve Stimulation. Journal of Clinical Gastroenterology. 49: 853-857. PMID 25930972 DOI: 10.1097/Mcg.0000000000000331 |
0.318 |
|
| 2015 |
Macé V, Ahluwalia A, Coron E, Le Rhun M, Boureille A, Bossard C, Mosnier JF, Matysiak-Budnik T, Tarnawski AS. Confocal laser endomicroscopy: a new gold standard for the assessment of mucosal healing in ulcerative colitis. Journal of Gastroenterology and Hepatology. 30: 85-92. PMID 25827810 DOI: 10.1111/Jgh.12748 |
0.6 |
|
| 2015 |
Droy-Dupré L, Bossard C, Volteau C, Bezieau S, Laboisse CL, Mosnier JF. Hierarchical clustering identifies a subgroup of colonic adenocarcinomas expressing crypt-like differentiation markers, associated with MSS status and better prognosis. Virchows Archiv : An International Journal of Pathology. 466: 383-91. PMID 25665656 DOI: 10.1007/S00428-015-1724-9 |
0.579 |
|
| 2015 |
Brissot E, Bossard C, Malard F, Braudeau C, Chevallier P, Guillaume T, Delaunay J, Josien R, Gregoire M, Gaugler B, Mohty M. Involvement of the CX3CL1 (fractalkine)/CX3CR1 pathway in the pathogenesis of acute graft-versus-host disease. Journal of Leukocyte Biology. 97: 227-35. PMID 25420917 DOI: 10.1189/Jlb.5Hi0714-325R |
0.363 |
|
| 2015 |
Loirat M, Chevallier P, Leux C, Moreau A, Bossard C, Guillaume T, Gastinne T, Delaunay J, Blin N, Mahé B, Dubruille V, Augeul-Meunier K, Peterlin P, Maisonneuve H, Moreau P, et al. Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 26: 386-92. PMID 25392158 DOI: 10.1093/Annonc/Mdu515 |
0.322 |
|
| 2015 |
Touchefeu Y, Provost-Dewitte M, Gounin S, Morel A, Valo I, Mosnier J, Bossard C, Eugene J, Chetritt J, Bezieau S, Senellart H, Caulet M, Cauchin E, Lecomte T, Matysiak-Budnik T. Sa1939 Clinical, Histological and Molecular Prognostic Factors for 3-Year Disease Free Survival in Patients With Stage II Colon Cancer Gastroenterology. 148. DOI: 10.1016/S0016-5085(15)31213-0 |
0.584 |
|
| 2015 |
Lamarque M, Contejean A, Bossard C, Fournier M, Brice P, Delarue R, Gaulard P, Haioun C. Brentuximab Vedotin in refractory or relapsed Peripheral T-cell Lymphoma: The French name patient program experience in 66 patients Clinical Lymphoma, Myeloma & Leukemia. 15. DOI: 10.1016/J.Clml.2015.04.098 |
0.309 |
|
| 2014 |
Khammari A, Knol AC, Nguyen JM, Bossard C, Denis MG, Pandolfino MC, Quéreux G, Bercegeay S, Dréno B. Adoptive TIL transfer in the adjuvant setting for melanoma: long-term patient survival. Journal of Immunology Research. 2014: 186212. PMID 24741578 DOI: 10.1155/2014/186212 |
0.326 |
|
| 2014 |
Sarrabayrouse G, Bossard C, Chauvin J, Jarry A, Meurette G, Quévrain E, Bridonneau C, Preisser L, Asehnoune K, Labarrière N, Altare F, Sokol H, Jotereau F. CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease. Plos Biology. 12. PMID 24714093 DOI: 10.1371/Journal.Pbio.1001833 |
0.402 |
|
| 2014 |
Küry S, Garrec C, Airaud F, Breheret F, Guibert V, Frenard C, Jiao S, Bonneau D, Berthet P, Bossard C, Ingster O, Cauchin E, Bezieau S. Evaluation of the colorectal cancer risk conferred by rare UNC5C alleles. World Journal of Gastroenterology. 20: 204-13. PMID 24415873 DOI: 10.3748/Wjg.V20.I1.204 |
0.314 |
|
| 2014 |
Loirat M, Chevalier P, Leux C, Moreau A, Bossard C, Guillaume T, Gastinne T, Delaunay J, Blin N, Mahe B, Dubruille V, Augel-Meunier K, Peterlin P, Maisonneuve H, Morineau N, et al. Upfront Allogeneic-Stem Cell Transplantation for Patients with Non-Localized Untreated Peripheral T-Cell Lymphoma: An Intention-to-Treat Analysis from a Single Center Blood. 124: 1217-1217. DOI: 10.1182/Blood.V124.21.1217.1217 |
0.327 |
|
| 2013 |
Malard F, Bossard C, Brissot E, Chevallier P, Guillaume T, Delaunay J, Mosnier JF, Moreau P, Grégoire M, Gaugler B, Mohty M. Increased plasmacytoid dendritic cells and RORγt-expressing immune effectors in cutaneous acute graft-versus-host disease. Journal of Leukocyte Biology. 94: 1337-43. PMID 23990625 DOI: 10.1189/Jlb.0513295 |
0.606 |
|
| 2013 |
Couturier M, Lamarthée B, Arbez J, Renauld JC, Bossard C, Malard F, Bonnefoy F, Mohty M, Perruche S, Tiberghien P, Saas P, Gaugler B. IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect. Leukemia. 27: 1527-37. PMID 23399894 DOI: 10.1038/Leu.2013.39 |
0.323 |
|
| 2013 |
Bossard C, Brissot E, Chevallier P, Guillaume T, Delaunay J, Mosnier jF, Moreau P, Gregoire M, Gaugler B, Mohty M. Increased Th17/Treg Ratio In Liver Chronic Graft-Versus-Host-Disease Blood. 122: 3251-3251. DOI: 10.1182/Blood.V122.21.3251.3251 |
0.364 |
|
| 2012 |
Bossard C, Küry S, Jamet P, Senellart H, Airaud F, Ramée JF, Bézieau S, Matysiak-Budnik T, Laboisse CL, Mosnier JF. Delineation of the infrequent mosaicism of KRAS mutational status in metastatic colorectal adenocarcinomas. Journal of Clinical Pathology. 65: 466-9. PMID 22259183 DOI: 10.1136/Jclinpath-2011-200608 |
0.586 |
|
| 2012 |
Perrin C, Cannata GE, Bossard C, Grill JM, Ambrossetti D, Michiels JF. Onychocytic matricoma presenting as pachymelanonychia longitudinal. A new entity (report of five cases). The American Journal of Dermatopathology. 34: 54-9. PMID 22197859 DOI: 10.1097/Dad.0B013E31822C3D8B |
0.313 |
|
| 2012 |
Bossard C, Bézieau S, Matysiak-Budnik T, Volteau C, Laboisse CL, Jotereau F, Mosnier JF. HLA-E/β2 microglobulin overexpression in colorectal cancer is associated with recruitment of inhibitory immune cells and tumor progression. International Journal of Cancer. 131: 855-63. PMID 21953582 DOI: 10.1002/Ijc.26453 |
0.632 |
|
| 2012 |
Droy-Dupré L, Vallée M, Bossard C, Laboisse CL, Jarry A. A multiparametric approach to monitor the effects of γ-secretase inhibition along the whole intestinal tract. Disease Models & Mechanisms. 5: 107-114. PMID 21885452 DOI: 10.1242/Dmm.007591 |
0.325 |
|
| 2012 |
Parrens M, Martin A, Lamant L, Delarue R, Haioun C, Tournilhac O, Berger F, Bossard C, Bouchind'homme B, Briere J, Canioni D, Charlotte F, Fabiani B, Molina TJ, Patey M, et al. Angioimmunoblastic T-Cell Lymphoma (AITL) Is the Most Prevalent T-Cell Lymphoma Entity in Western Europe Blood. 120: 1607-1607. DOI: 10.1182/Blood.V120.21.1607.1607 |
0.352 |
|
| 2011 |
Jarry A, Bossard C, Sarrabayrouse G, Mosnier JF, Laboisse CL. Loss of interleukin-10 or transforming growth factor β signaling in the human colon initiates a T-helper 1 response via distinct pathways. Gastroenterology. 141: 1887-96.e1-2. PMID 21839042 DOI: 10.1053/J.Gastro.2011.08.002 |
0.591 |
|
| 2011 |
Sarrabayrouse G, Corvaisier M, Ouisse LH, Bossard C, Le Mével B, Potiron L, Meurette G, Gervois N, Jotereau F. Tumor-reactive CD4+ CD8αβ+ CD103+ αβT cells: a prevalent tumor-reactive T-cell subset in metastatic colorectal cancers. International Journal of Cancer. 128: 2923-32. PMID 20824715 DOI: 10.1002/Ijc.25640 |
0.429 |
|
| 2011 |
Malard F, Bossard C, Arbez J, Chevallier P, Guillaume T, Delaunay J, Mosnier J, Saas P, Mohty M, Gaugler B. Plasmacytoid Dendritic Cells (PDC) and Th17 Immune Response Contribution in Gut Acute Graft-Versus-Host-Disease (GVHD) Blood. 118: 2968-2968. DOI: 10.1182/Blood.V118.21.2968.2968 |
0.627 |
|
| 2007 |
Bossard C, Denis MG, Bézieau S, Bach-Ngohou K, Bourreille A, Laboisse CL, Mosnier JF. Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis. Oncology Reports. 18: 1093-7. PMID 17914558 DOI: 10.3892/Or.18.5.1093 |
0.59 |
|
| 2007 |
Svrcek M, El-Bchiri J, Chalastanis A, Capel E, Dumont S, Buhard O, Oliveira C, Seruca R, Bossard C, Mosnier JF, Berger F, Leteurtre E, Lavergne-Slove A, Chenard MP, Hamelin R, et al. Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 4231-8. PMID 17878476 DOI: 10.1200/Jco.2007.10.9744 |
0.602 |
|
| 2007 |
Bossard C, Souazé F, Jarry A, Bezieau S, Mosnier JF, Forgez P, Laboisse CL. Over-expression of neurotensin high-affinity receptor 1 (NTS1) in relation with its ligand neurotensin (NT) and nuclear beta-catenin in inflammatory bowel disease-related oncogenesis. Peptides. 28: 2030-5. PMID 17870207 DOI: 10.1016/J.Peptides.2007.06.030 |
0.589 |
|
| 2007 |
Bossard C, Belhadj K, Reyes F, Martin-Garcia N, Berger F, Kummer JA, Brière J, Baglin A, Cheze S, Bosq J, Ribrag V, Gisselbrecht C, Mounier N, Gaulard P. Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood. 109: 2183-2189. PMID 17077322 DOI: 10.1182/Blood-2006-07-033142 |
0.382 |
|
| 2006 |
Bossard C, Jarry A, Colombeix C, Bach-Ngohou K, Moreau A, Loussouarn D, Mosnier J, Laboisse CL. Phosphohistone H3 labelling for histoprognostic grading of breast adenocarcinomas and computer-assisted determination of mitotic index. Journal of Clinical Pathology. 59: 706-710. PMID 16461563 DOI: 10.1136/Jcp.2005.030452 |
0.549 |
|
| 2006 |
Blin N, Bossard C, Harousseau J, Charbonnel C, Gouraud W, Campion L, Magrangeas F, Minvielle S, Loiseau HA. Gene Expression Profiling Comparison between the Major Mature B-Cell Neoplasms and Their Normal Cellular and Anatomic Counterparts: Identification of Candidate Genes Potentially Involved in Lymphomagenesis. Blood. 108: 2375-2375. DOI: 10.1182/Blood.V108.11.2375.2375 |
0.325 |
|
| 2004 |
Bossard C, Belhadj K, Reyes F, Martin-Garcia N, Kümmer A, Berger F, Brière J, Baglin A, Casiraghi O, Lepage E, Gaulard P. Primary Nasal NK/T Cell Lymphoma: Cytology and Level of the Antiapoptotic PI9 Protein Have Prognostic Relevance. Blood. 104: 3264-3264. DOI: 10.1182/Blood.V104.11.3264.3264 |
0.385 |
|
| Show low-probability matches. |